Navigation Links
VaxGen Reports Financial Update
Date:3/6/2008

for more information about Raven biotechnologies inc.

Note: This press release contains "forward-looking statements" within the meaning of the federal securities laws. These forward-looking statements include, without limitation, the benefits of the proposed merger, the business potential of the combined company as well as any potential non-cash impairment charge related to VaxGen's facility. These statements are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated. Additional information concerning these and other risk factors is contained in VaxGen's Annual Report on Form 10-K for the year ended December 31, 2006, the most recently filed Quarterly Report on Form10-Q and the Form S-4 filed on February 6, 2008. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this release. VaxGen and Raven undertake no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.

Additional Information and Where to Find It

VaxGen has filed a registration statement on Form S-4, and a related proxy statement/prospectus, in connection with the merger. Investors and security holders are urged to read the registration statement on Form S-4 and the related proxy statement/prospectus because they will contain important information about the merger transaction. Investors and security holders may obtain free copies of these documents (when they are available) and other documents filed with the SEC at the SEC's web site at http://www.sec.gov. In addition, investors and security holders may obtain free copies of the documents filed with the SEC by contacting VaxGen Investor Relations at the email address: ir@vaxgen.com.

This communicat
'/>"/>

SOURCE VaxGen Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. VaxGen to Present at the 10th Annual BIO CEO and Investor Conference
2. VaxGen and Raven Announce Form S4 Registration Statement Declared Effective
3. VaxGen Stockholders Overwhelmingly Approve Reverse Split Proposal
4. VaxGen Common Stock Expected to Qualify for Quotation on OTC Bulletin Board
5. VaxGen Addresses MPM Claims in Letter to Stockholders
6. VaxGen Files Last Outstanding Periodic Report With SEC
7. Jack Anthony to Resign From VaxGens Board After Accepting CEO Position at Osprey Pharmaceuticals
8. VaxGen Files First Quarter 2007 Financials
9. VaxGen Further Restructures to Preserve Cash as It Pursues Strategic Initiatives
10. VaxGen Files 2006 Financial Statements and Provides Cash Update
11. EntreMed Reports Fourth Quarter and Year-End 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... Ill. , July 23, 2014 /PRNewswire/ ... (SNA™) constructs as gene regulatory and immunotherapeutic ... has joined AuraSense Therapeutics, executive leadership ... 11. Prior to joining AuraSense ... and Chief Financial Officer of Cellular Dynamics ...
(Date:7/23/2014)... 23 de julio de 2014 ADB ... Compañía) ha anunciado hoy una asociación con Austen ... (ABIA o el Instituto), para el propósito de ... de terapia de señal bioeléctrica (el E-QURE BST ... Instituto, que tiene una importante experiencia en cicatrización ...
(Date:7/23/2014)... 2014 /PRNewswire/ - BioAmber Inc. (NYSE: ... chemicals, today announced that the underwriters of its common ... purchase an additional 420,000 shares of common stock ... share, less underwriting discounts and commissions, in connection ... 2,800,000 shares of common stock, bringing the expected ...
(Date:7/23/2014)... PARK, Calif. , July 23, 2014  Sofinnova ... investment firm, today announced the closing of Sofinnova Venture ... million and in excess of the initial fund target ... helping entrepreneurs build successful biotechnology companies. Consistent with recent ... with promising later stage clinical programs, along with select ...
Breaking Biology Technology:AuraSense Therapeutics Appoints Biotechnology Veteran David S. Snyder as Chief Financial Officer 2ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 2ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 3ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 4ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 5ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 6BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 2BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 3Sofinnova Raises $500 Million Biotech Venture Fund 2
... $68.6 Million, Increase of 32% Over Second Quarter 2007, - EPS of ... - Earnings Before Non-Cash Charges of $1.36 per Basic Share, Increase of ... 56% Over Second ... UTHR ) today announced its results of,operations for the quarter ended ...
... California, Berkeley, have devised a way to squeeze light ... doors to new technology in the fields of optical ... succeeded previously in passing light through gaps 200 nanometers ... a human hair. A group of UC Berkeley researchers ...
... Inc.,(Nasdaq: ITMN ) today announced that Daniel G. ... the BMO Capital Markets 2008 Focus,on Healthcare Conference in ... EDT., To access a live audio webcast of ... to the investor relations page of InterMune,s,corporate website at ...
Cached Biology Technology:United Therapeutics Reports Second Quarter 2008 Financial Results 2United Therapeutics Reports Second Quarter 2008 Financial Results 3United Therapeutics Reports Second Quarter 2008 Financial Results 4United Therapeutics Reports Second Quarter 2008 Financial Results 5United Therapeutics Reports Second Quarter 2008 Financial Results 6New technique to compress light could open doors for optical communications 2New technique to compress light could open doors for optical communications 3
(Date:7/23/2014)... In Aesop,s fable about the crow and the pitcher, a ... he tries to drink from it, he finds the water ... over the pitcher, the bird drops pebbles into it ... enough for him to drink his fill. , Highlighting the ... often be more effective than brute force. It also characterizes ...
(Date:7/23/2014)... satellite over a 15-year period off the U.S. West ... in specific locations each year, according to a study ... PLOS ONE by Ladd Irvine from Oregon State ... mitigate human threats to the whale population. , The ... since the establishment of protections in the mid-1960s. Scientists ...
(Date:7/23/2014)... Spinach gave Popeye super strength, but it also ... group of scientists: the ability to convert sunlight into ... are part of an international group using spinach to ... which plants convert the sun,s energy into carbohydrates used ... are part of the most efficient system ever built, ...
Breaking Biology News(10 mins):Smarter than a first-grader? 2Smarter than a first-grader? 3Smarter than a first-grader? 4Blue whales' dangerous feeding grounds 2Spinach could lead to alternative energy more powerful than Popeye 2
... study of men and post-menopausal women primarily over 60 ... with greater bone mineral density (BMD). Researchers at the ... (USDA HNRCA) at Tufts University found associations were strongest ... lower in men drinking more than two servings of ...
... -- Ben-Gurion University of the Negev (BGU) researchers have ... reversible panes that will save energy all year round ... Window, features the only glazing system that permits effective ... temperature near a window and reduces unwanted solar gains ...
... of the American Dietetic Association features research studies ... of the life cycle, from children and adolescents to ... Consumption among U.S. Children , Children and adolescents ... to researchers at Ohio State University. The researchers ...
Cached Biology News:Moderate alcohol intake associated with bone protection 2Moderate alcohol intake associated with bone protection 3Ben-Gurion University of the Negev researchers develop new reversible, green window technology 2News from the March 2009 Journal of the American Dietetic Association 2
Lentigen's manufacturing platform is sufficiently versatile for use in the manufacture of any HIV-based Lentiviral vector. Lentigen will manufacture your LV of choice to the highest possible titer a...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Biology Products: